Armstrong, A. W., Lebwohl, M., Warren, R. B., Sofen, H., Imafuku, S. ., Ohtsuki, M., Spelman, L. ., Passeron, T., Papp, K. A., Kisa, R. M., Berger, V., Vritzali, E., Hoyt, K., Colombo, M. J., Banerjee, S., Strober, B., Thaçi, D., & Blauvelt, A. (2024). Deucravacitinib in Plaque Psoriasis: 3-year Safety and Efficacy Results from the Phase 3 POETYK PSO-1 and PSO-2 Trials. SKIN The Journal of Cutaneous Medicine, 8(2), s366. https://doi.org/10.25251/skin.8.supp.366